Gilead Sciences Inc
(LIM:GILD)
$
75.83
0 (0%)
Market Cap: 79.19 Bil
Enterprise Value: 99.66 Bil
PE Ratio: 176.44
PB Ratio: 4.52
GF Score: 77/100 - Q1 2024 Gilead Sciences Inc Earnings Call TranscriptApr 25, 2024$75.83Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2024
- Gilead Sciences Inc at Leerink Partners Global Biopharma Conference TranscriptMar 12, 2024
- Gilead Sciences Inc at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Gilead Sciences Inc Earnings Call TranscriptFeb 06, 2024$75.83Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Gilead Sciences Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Gilead Sciences Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2023
- Q3 2023 Gilead Sciences Inc Earnings Call TranscriptNov 07, 2023$79.2Earnings
- Assembly Biosciences Inc Partnership with Gilead Sciences Inc to Develop Next-Generation Antiviral Therapeutics Call TranscriptOct 17, 2023
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Gilead Sciences Inc at Wells Fargo Healthcare Conference TranscriptSep 06, 2023
- Q2 2023 Gilead Sciences Inc Earnings Call TranscriptAug 03, 2023$79.2Earnings
- Gilead Sciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Gilead Sciences Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Gilead Sciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Gilead Sciences Inc Earnings Call TranscriptApr 27, 2023$79.2Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Gilead Sciences Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Gilead Sciences Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Q4 2022 Gilead Sciences Inc Earnings Call TranscriptFeb 02, 2023$79.2Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Gilead Sciences Inc and Arcus Biosciences Inc Post ARC-7 Plenary Q&A TranscriptDec 20, 2022
- Gilead Sciences Inc at Nasdaq Investor Conference TranscriptDec 07, 2022
- Gilead Sciences Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Gilead Sciences Inc Earnings Call TranscriptOct 27, 2022$63.3Earnings
- Gilead Sciences Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Gilead Sciences Inc at Wells Fargo Healthcare Conference TranscriptSep 08, 2022
- Q2 2022 Gilead Sciences Inc Earnings Call TranscriptAug 02, 2022$63.3Earnings
- Gilead Sciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 08, 2022
- Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference TranscriptJun 02, 2022
- Gilead Sciences Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Gilead Sciences Inc Earnings Call TranscriptApr 28, 2022$60.08Earnings
- Gilead Sciences Inc Oncology Deep Dive TranscriptApr 14, 2022
- Gilead Sciences Inc at Cowen Health Care Conference (Virtual) TranscriptMar 09, 2022
- Gilead Sciences Inc at Raymond James Institutional Investors Conference TranscriptMar 08, 2022
- Gilead Sciences Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 16, 2022
- Q4 2021 Gilead Sciences Inc Earnings Call TranscriptFeb 01, 2022$72.02Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Gilead Sciences Inc at Evercore ISI HealthCONx Virtual Conference TranscriptDec 02, 2021
- Arcus Biosciences to Discuss the Expanded Partnership with Gilead Sciences Inc- Conference Call TranscriptNov 18, 2021
- Q3 2021 Gilead Sciences Inc Earnings Call TranscriptOct 28, 2021$72.2Earnings
- Gilead Sciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Q2 2021 Gilead Sciences Inc Earnings Call TranscriptJul 29, 2021$68.6Earnings
- Gilead Sciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Gilead Sciences Inc at Sanford C Bernstein Strategic Decisions Conference (Virtual) TranscriptJun 02, 2021
- Gilead Sciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Gilead Sciences Inc at Cowen Virtual Oncology Innovation Summit TranscriptMay 21, 2021
- Gilead Sciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 19, 2021
- Gilead Sciences Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 Gilead Sciences Inc Earnings Call TranscriptApr 29, 2021$63.7 (-1.09%)Earnings
- Merck & Co to Discuss Broad HIV Development Program and Newly Announced Collaboration with Gilead Sciences Inc - Conference Call TranscriptMar 15, 2021
- Gilead Sciences Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 04, 2021
- Gilead Sciences Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2021Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Galapagos NV & Gilead Sciences Inc to Announce New Commercialization and Development Agreement for Rheumatoid Arthritis Treatment Call TranscriptDec 16, 2020
- Gilead Sciences Inc at Evercore ISI HealthCONx Conference TranscriptDec 02, 2020
- Q3 2020 Gilead Sciences Inc Earnings Call TranscriptOct 28, 2020Earnings
- Gilead Sciences Inc to Acquire Immunomedics Inc Conference Call TranscriptSep 13, 2020
- Q2 2020 Gilead Sciences Inc Earnings Call TranscriptJul 30, 2020Earnings
- Gilead Sciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 04, 2020
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 06, 2020
- Q1 2020 Gilead Sciences Inc Earnings Call TranscriptApr 30, 2020Earnings
- Gilead Sciences Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Gilead Sciences Inc to Acquire Forty Seven Inc - Conference Call TranscriptMar 02, 2020
- Q4 2019 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2020Earnings
- Gilead Sciences Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Gilead Sciences Inc Earnings Call TranscriptOct 24, 2019Earnings
- Gilead Sciences Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Gilead Sciences Inc Earnings Call TranscriptJul 30, 2019Earnings
- Gilead Sciences Inc and Galapagos NV Enter Into Transformative Research and Development Collaboration Call TranscriptJul 14, 2019
- Gilead Sciences Inc at Jefferies Healthcare Conference TranscriptJun 05, 2019
- Gilead Sciences Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Gilead Sciences Inc Annual Shareholders Meeting TranscriptMay 08, 2019
- Q1 2019 Gilead Sciences Inc Earnings Call TranscriptMay 02, 2019Earnings
- Gilead Sciences Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Gilead Sciences Inc Earnings Call TranscriptFeb 04, 2019Earnings
Gilead Sciences Inc at Leerink Partners Global Biopharma Conference Transcript
Mar 12, 2024 / 02:00PM GMT
Release Date Price:
$75.83
Daina Michelle Graybosch
Leerink Partners LLC, Research Division - Senior MD of Immuno-Oncology and Senior Research Analyst
Okay. Good morning, everyone. My name is Daina Graybosch. I am analyst here at Leerink Partners. My team and I cover immuno-oncology and broader. And we -- one of the companies we cover is Gilead, and we're really excited today to host Cindy Perettie from Kite.
Cindy Perettie
Gilead Sciences, Inc. - EVP of Kite
Thank you. It's nice to be here.
Questions & Answers
Daina Michelle Graybosch
Leerink Partners LLC, Research Division - Senior MD of Immuno-Oncology and Senior Research Analyst
And so we're going to jump right in, because it's a busy year and busy week for CAR T. And we're going to talk all elements. So actually, let's start with BCMA. So Kite has licensed Arcellx's BCMA CAR T called Anito-Cel. And I wonder if you could talk about of all the potentially differentiating product attributes for Anito-Cel, which do you think will be most impactful in commercialization?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)